These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1638588

  • 1. Efficacy of cefaclor AF in the treatment of skin and skin-structure infections.
    Schupbach CW, Olovich KG, Dere WH.
    Clin Ther; 1992; 14(3):470-9. PubMed ID: 1638588
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicentre trial of cefaclor advanced formulation versus cefaclor in the treatment of acute bronchitis.
    Alanis A, Longest KA, Senetar JE, Dere WH.
    Postgrad Med J; 1992; 68 Suppl 3():S24-8, discussion S29. PubMed ID: 1287614
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative efficacy of cefadroxil and cefaclor in the treatment of skin and soft-tissue infections.
    Ballantyne FN.
    Clin Ther; 1985; 7(4):487-91. PubMed ID: 4016827
    [Abstract] [Full Text] [Related]

  • 7. Cefaclor AF versus cefaclor in acute exacerbations of chronic bronchitis.
    Grossman RF.
    Postgrad Med J; 1992; 68 Suppl 3():S30-6; discussion S36-7. PubMed ID: 1287616
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comprehensive safety profile of cefaclor AF in respiratory, urinary tract and skin infections.
    Stotka JL, Senetar JE, Therasse DG, Dere WH.
    Postgrad Med J; 1992; 68 Suppl 3():S73-7; discussion S78-80. PubMed ID: 1287622
    [Abstract] [Full Text] [Related]

  • 10. Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult population.
    McCarty J, Ruoff GE, Jacobson KD.
    Am J Med; 1992 Jun 22; 92(6A):80S-85S. PubMed ID: 1621751
    [Abstract] [Full Text] [Related]

  • 11. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC, Gray BM, Ware JC.
    Postgrad Med J; 1979 Jun 22; 55 Suppl 4():77-81. PubMed ID: 548944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Loracarbef vs. cefaclor in pediatric skin and skin structure infections.
    Hanfling MJ, Hausinger SA, Squires J.
    Pediatr Infect Dis J; 1992 Aug 22; 11(8 Suppl):S27-30. PubMed ID: 1513609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.